In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer

Michalina Janiszewska, Lin Liu, Vanessa Almendro, Yanan Kuang, Cloud Paweletz, Rita A. Sakr, Britta Weigelt, Ariella B. Hanker, Sarat Chandarlapaty, Tari A. King, Jorge S. Reis-Filho, Carlos L. Arteaga, So Yeon Park, Franziska Michor, Kornelia Polyak

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Detection of minor, genetically distinct subpopulations within tumors is a key challenge in cancer genomics. Here we report STAR-FISH (specific-to-allele PCR-FISH), a novel method for the combined detection of single-nucleotide and copy number alterations in single cells in intact archived tissues. Using this method, we assessed the clinical impact of changes in the frequency and topology of PIK3CA mutation and HER2 (ERBB2) amplification within HER2-positive breast cancer during neoadjuvant therapy. We found that these two genetic events are not always present in the same cells. Chemotherapy selects for PIK3CA-mutant cells, a minor subpopulation in nearly all treatment-naive samples, and modulates genetic diversity within tumors. Treatment-associated changes in the spatial distribution of cellular genetic diversity correlated with poor long-term outcome following adjuvant therapy with trastuzumab. Our findings support the use of in situ single cell-based methods in cancer genomics and imply that chemotherapy before HER2-targeted therapy may promote treatment resistance.

Original languageEnglish (US)
Pages (from-to)1212-1219
Number of pages8
JournalNature Genetics
Volume47
Issue number10
DOIs
StatePublished - Sep 29 2015

Fingerprint

Single-Cell Analysis
Breast Neoplasms
Mutation
Genomics
Neoplasms
Therapeutics
Drug Therapy
Neoadjuvant Therapy
Nucleotides
Alleles
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Genetics

Cite this

Janiszewska, M., Liu, L., Almendro, V., Kuang, Y., Paweletz, C., Sakr, R. A., ... Polyak, K. (2015). In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer. Nature Genetics, 47(10), 1212-1219. https://doi.org/10.1038/ng.3391

In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer. / Janiszewska, Michalina; Liu, Lin; Almendro, Vanessa; Kuang, Yanan; Paweletz, Cloud; Sakr, Rita A.; Weigelt, Britta; Hanker, Ariella B.; Chandarlapaty, Sarat; King, Tari A.; Reis-Filho, Jorge S.; Arteaga, Carlos L.; Park, So Yeon; Michor, Franziska; Polyak, Kornelia.

In: Nature Genetics, Vol. 47, No. 10, 29.09.2015, p. 1212-1219.

Research output: Contribution to journalArticle

Janiszewska, M, Liu, L, Almendro, V, Kuang, Y, Paweletz, C, Sakr, RA, Weigelt, B, Hanker, AB, Chandarlapaty, S, King, TA, Reis-Filho, JS, Arteaga, CL, Park, SY, Michor, F & Polyak, K 2015, 'In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer', Nature Genetics, vol. 47, no. 10, pp. 1212-1219. https://doi.org/10.1038/ng.3391
Janiszewska, Michalina ; Liu, Lin ; Almendro, Vanessa ; Kuang, Yanan ; Paweletz, Cloud ; Sakr, Rita A. ; Weigelt, Britta ; Hanker, Ariella B. ; Chandarlapaty, Sarat ; King, Tari A. ; Reis-Filho, Jorge S. ; Arteaga, Carlos L. ; Park, So Yeon ; Michor, Franziska ; Polyak, Kornelia. / In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer. In: Nature Genetics. 2015 ; Vol. 47, No. 10. pp. 1212-1219.
@article{bda0e3679ef04b94bfcf20c80c1a5b02,
title = "In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer",
abstract = "Detection of minor, genetically distinct subpopulations within tumors is a key challenge in cancer genomics. Here we report STAR-FISH (specific-to-allele PCR-FISH), a novel method for the combined detection of single-nucleotide and copy number alterations in single cells in intact archived tissues. Using this method, we assessed the clinical impact of changes in the frequency and topology of PIK3CA mutation and HER2 (ERBB2) amplification within HER2-positive breast cancer during neoadjuvant therapy. We found that these two genetic events are not always present in the same cells. Chemotherapy selects for PIK3CA-mutant cells, a minor subpopulation in nearly all treatment-naive samples, and modulates genetic diversity within tumors. Treatment-associated changes in the spatial distribution of cellular genetic diversity correlated with poor long-term outcome following adjuvant therapy with trastuzumab. Our findings support the use of in situ single cell-based methods in cancer genomics and imply that chemotherapy before HER2-targeted therapy may promote treatment resistance.",
author = "Michalina Janiszewska and Lin Liu and Vanessa Almendro and Yanan Kuang and Cloud Paweletz and Sakr, {Rita A.} and Britta Weigelt and Hanker, {Ariella B.} and Sarat Chandarlapaty and King, {Tari A.} and Reis-Filho, {Jorge S.} and Arteaga, {Carlos L.} and Park, {So Yeon} and Franziska Michor and Kornelia Polyak",
year = "2015",
month = "9",
day = "29",
doi = "10.1038/ng.3391",
language = "English (US)",
volume = "47",
pages = "1212--1219",
journal = "Nature Genetics",
issn = "1061-4036",
publisher = "Nature Publishing Group",
number = "10",

}

TY - JOUR

T1 - In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer

AU - Janiszewska, Michalina

AU - Liu, Lin

AU - Almendro, Vanessa

AU - Kuang, Yanan

AU - Paweletz, Cloud

AU - Sakr, Rita A.

AU - Weigelt, Britta

AU - Hanker, Ariella B.

AU - Chandarlapaty, Sarat

AU - King, Tari A.

AU - Reis-Filho, Jorge S.

AU - Arteaga, Carlos L.

AU - Park, So Yeon

AU - Michor, Franziska

AU - Polyak, Kornelia

PY - 2015/9/29

Y1 - 2015/9/29

N2 - Detection of minor, genetically distinct subpopulations within tumors is a key challenge in cancer genomics. Here we report STAR-FISH (specific-to-allele PCR-FISH), a novel method for the combined detection of single-nucleotide and copy number alterations in single cells in intact archived tissues. Using this method, we assessed the clinical impact of changes in the frequency and topology of PIK3CA mutation and HER2 (ERBB2) amplification within HER2-positive breast cancer during neoadjuvant therapy. We found that these two genetic events are not always present in the same cells. Chemotherapy selects for PIK3CA-mutant cells, a minor subpopulation in nearly all treatment-naive samples, and modulates genetic diversity within tumors. Treatment-associated changes in the spatial distribution of cellular genetic diversity correlated with poor long-term outcome following adjuvant therapy with trastuzumab. Our findings support the use of in situ single cell-based methods in cancer genomics and imply that chemotherapy before HER2-targeted therapy may promote treatment resistance.

AB - Detection of minor, genetically distinct subpopulations within tumors is a key challenge in cancer genomics. Here we report STAR-FISH (specific-to-allele PCR-FISH), a novel method for the combined detection of single-nucleotide and copy number alterations in single cells in intact archived tissues. Using this method, we assessed the clinical impact of changes in the frequency and topology of PIK3CA mutation and HER2 (ERBB2) amplification within HER2-positive breast cancer during neoadjuvant therapy. We found that these two genetic events are not always present in the same cells. Chemotherapy selects for PIK3CA-mutant cells, a minor subpopulation in nearly all treatment-naive samples, and modulates genetic diversity within tumors. Treatment-associated changes in the spatial distribution of cellular genetic diversity correlated with poor long-term outcome following adjuvant therapy with trastuzumab. Our findings support the use of in situ single cell-based methods in cancer genomics and imply that chemotherapy before HER2-targeted therapy may promote treatment resistance.

UR - http://www.scopus.com/inward/record.url?scp=84942987073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942987073&partnerID=8YFLogxK

U2 - 10.1038/ng.3391

DO - 10.1038/ng.3391

M3 - Article

VL - 47

SP - 1212

EP - 1219

JO - Nature Genetics

JF - Nature Genetics

SN - 1061-4036

IS - 10

ER -